The economic burden of schizophrenia in the United States in 2002

Eric Q Wu, Howard G Birnbaum, Lizheng Shi, Daniel E Ball, Ronald C Kessler, Matthew Moulis, Jyoti Aggarwal
2005-09-09
Abstract:Objective: This study quantifies excess annual costs associated with schizophrenia patients in the United States in 2002 from a societal perspective. Method: Annual direct medical costs associated with schizophrenia were estimated separately for privately (N= 1090) and publicly (Medicaid; N= 14,074) insured patients based on administrative claims data, including a large private claims database and the California Medicaid program (Medi-Cal) database, and compared separately to demographically/geographically matched control samples (1 case: 3 controls). Medicare costs of patients over age 65 years were imputed using the Medicare/Medi-Cal dual-eligible patients (N= 1491) and published statistics. Excess annual direct non–health care costs were estimated for law enforcement, homeless shelters, and research/training related to schizophrenia. Excess annual indirect costs were estimated for 4 components of productivity loss: unemployment, reduced workplace productivity, premature …
What problem does this paper attempt to address?